DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of ...

DBV Technologies stock opened at $4.19 on Thursday. The firm has a 50 day simple moving average of $4.06 and a 200-day simple moving average of $3.83. The stock has a market capitalization of $86. ...